Lexicon Pharmaceuticals | LXRX - 当期純利益





当期純利益 変化する 日付
Abbott USD 1.08B 699M 2026-03
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
AstraZeneca USD 3.08B 754M 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Coherus Biosciences USD -37.64M 2.11M 2025-12
Eli Lilly USD 7.4B 760M 2026-03
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Halozyme Therapeutics USD -141.59M 316.82M 2025-12
Illumina USD 134M 200M 2026-03
Insmed USD -328.48M 41.54M 2025-12
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
J&J USD 5.24B 119M 2026-03
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
MacroGenics USD -14.16M 30.98M 2025-12
MannKind USD -15.95M 23.93M 2025-12
Merck USD -4.24B 7.2B 2026-03
Moderna USD -1.34B 517M 2026-03
Novartis USD 3.16B 747M 2026-03
PTC Therapeutics USD -134.96M 150.86M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Thermo Fisher Scientific USD 1.65B 313M 2026-03
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
United Therapeutics USD 364.3M 25.6M 2025-12
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12